Frank Rösch

Overview

Best Publications

• Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving.

  Andreas Heinz;Thomas Siessmeier;Jana Wrase;Derik Hermann

  676
  Citations

• Processing of Generator-Produced 68Ga for Medical Application

  Konstantin P. Zhernosekov;Dimitry V. Filosofov;Richard P. Baum;Peter Aschoff

  609
  Citations

• Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients.

  Andreas Heinz;Thomas Siessmeier;Jana Wrase;Hans Georg Buchholz

  353
  Citations

• Association of Low Striatal Dopamine D2 Receptor Availability With Nicotine Dependence Similar to That Seen With Other Drugs of Abuse

  Christoph Fehr;Igor Yakushev;Nina Hohmann;Hans-Georg Buchholz

  244
  Citations

• The Impact of Radioactivity on Medicine Metallic

  G. Stöcklin;S. M. Qaim;F. Rösch

  218
  Citations

• High opiate receptor binding potential in the human lateral pain system.

  Ulf Baumgärtner;Hans-Georg Buchholz;Alexander Bellosevich;Walter Magerl

  204
  Citations

• Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of (86)Y-DOTATOC and (111)In-DTPA-octreotide.

  Gregor J. Förster;Martin Engelbach;Jörg Brockmann;Helmut Reber

  184
  Citations

• A Triazacyclononane‐Based Bifunctional Phosphinate Ligand for the Preparation of Multimeric 68Ga Tracers for Positron Emission Tomography

  Johannes Notni;Johannes Notni;Petr Hermann;Jana Havlíčková;Jan Kotek

  182
  Citations

• Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS

  Frank Rösch;Richard P. Baum

  180
  Citations

• Measurement of Pharmacokinetics of Yttrium-86 Radiopharmaceuticals with PET and Radiation Dose Calculation of Analogous Yttrium-90 Radiotherapeutics

  Hans Herzog;Frank Rösch;Gerhard Stöcklin;Christoph Lueders

  170
  Citations

• Positron emission tomography in CNS drug discovery and drug monitoring.

  Markus Piel;Ingo Vernaleken;Frank Rösch

  159
  Citations

• Nuclear Data Relevant to the Production of the Positron Emitting Radioisotope 86Y via the 86Sr(p,n)- and natRb(3He,xn)-Processes

  F. Rösch;S. M. Qaim;G. Stöcklin

  151
  Citations

• A 44Ti/44Sc radionuclide generator for potential application of 44Sc-based PET-radiopharmaceuticals

  D. V. Filosofov;N. S. Loktionova;Frank Rösch

  146
  Citations

• Uptake kinetics of the somatostatin receptor ligand [86Y]DOTA-DPhe1- Tyr3-octreotide ([86Y]SMT487) using positron emission tomography in non-human primates and calculation of radiation doses of the 90Y-labelled analogue.

  Frank Rösch;Hans Herzog;Barbara Stolz;Jörg Brockmann

  146
  Citations

• PET/CT imaging of osteoblastic bone metastases with (68)Ga-bisphosphonates: first human study.

  Marco Fellner;Richard P. Baum;Vojtěch Kubíček;Petr Hermann

  135
  Citations

• PET-pharmacokinetics of 18F-octreotide: A comparison with 67Ga-DFO and 86Y-DTPA-octreotide

  Hans-Jürgen Wester;Jörg Brockmann;Frank Rösch;Walter Wutz

  124
  Citations

• Radioactive labeling of defined HPMA-based polymeric structures using [18F]FETos for in vivo imaging by positron emission tomography.

  Matthias M Herth;Matthias Barz;Dorothea Moderegger;Mareli Allmeroth

  123
  Citations

• The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.

  Gerhard Gründer;Gerhard Gründer;Christian Landvogt;Ingo Vernaleken;Ingo Vernaleken;Hans Georg Buchholz

  122
  Citations

• Production of the Positron Emitting Radioisotope 86Y for Nuclear Medical Application

  F. Rösch;S.M. Qaim;G. Stöcklin

  118
  Citations

• Electron- and Positron-Emitting Radiolanthanides for Therapy: Aspects of Dosimetry and Production

  Helena Uusijärvi;Peter Bernhardt;Frank Rösch;Helmut R Maecke

  117
  Citations